Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR) [Phase 3]

View source ↗

Summary

Phase 3 trial ARMOR evaluating Aramchol for nonalcoholic steatohepatitis is currently suspended; results were posted on 2024-12-16.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Aramchol

Snippet

Sponsor: Galmed Research and Development, Ltd. | Conditions: Nonalcoholic Steatohepatitis (NASH) | Phase 3 | Status: SUSPENDED | Results posted: 2024-12-16